1.
Tech Coloproctol
; 23(4): 379-383, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30989414
2.
J Virol
; 73(9): 7899-902, 1999 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-10438888
RESUMO
Mouse mammary tumor virus (MMTV) has been shown to preferentially infect B lymphocytes in vivo. We have used recombinant envelope-coated fluospheres and highly purified MMTV particles to study the distribution of the viral receptors on fresh mouse lymphocytes. A preferential dose-dependent binding to B lymphocytes was observed which could be competed with neutralizing antibodies. In contrast, T-lymphocyte binding remained at background levels. These results strongly suggest a higher density of viral receptor molecules on B lymphocytes than on T lymphocytes and correlate with the preferential initial infection of B lymphocytes observed in vivo.